← The Wire
PMNNasdaq
ProMIS Neurosciences Inc.
Pharmaceutical Preparations · Z4 · CIK 1374339
Develops antibody therapies targeting toxic misfolded proteins for neurodegenerative diseases
red 8-K · 90d
$93M
Market cap
$10.75
Last close
+2.1%
1D
+0.7%
5D
19K
Volume
Price · last 39 sessions-2.9%
May 4L $9.13 · H $11.07Jun 29
100
Total filings
May 20, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteMay 20, 202610-Q10-QMay 12, 20268-KResults of OperationsMay 12, 2026DEFA14ADEFA14AApr 9, 2026DEF 14ADEF 14AApr 9, 202610-K10-KMar 25, 20268-KResults of OperationsMar 25, 2026SC 13D/ASC 13D/AFeb 5, 2026SC 13D/ASC 13D/AFeb 2, 20268-KMaterial Agreement · Equity IssuanceJan 30, 20268-KCompany UpdateDec 16, 20258-KBylaw Amendment · Company UpdateNov 24, 20258-KShareholder VoteNov 19, 202510-Q10-QNov 12, 20258-KResults of OperationsNov 12, 20258-KExecutive Change · Reg FD DisclosureOct 24, 2025DEFA14ADEFA14AOct 3, 2025DEF 14ADEF 14AOct 3, 20258-KExecutive ChangeSep 30, 20258-KReg FD Disclosure · Company UpdateSep 3, 20258-KMaterial AgreementAug 19, 202510-Q10-QAug 13, 20258-KResults of OperationsAug 13, 20258-KMaterial Agreement · Equity IssuanceJul 28, 20258-KMaterial Agreement · Equity IssuanceJul 22, 2025424B5424B5Jul 22, 20258-KMaterial Agreement · Company UpdateJul 22, 20258-KCompany UpdateJul 7, 20258-KExecutive Change · Shareholder VoteJun 13, 202510-Q10-QMay 12, 20258-KResults of OperationsMay 12, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 2025424B5424B5Mar 31, 20258-KResults of OperationsMar 31, 202510-K10-KMar 31, 20258-KReg FD DisclosureFeb 25, 20258-KExecutive ChangeFeb 19, 20258-KReg FD DisclosureJan 27, 20258-KReg FD Disclosure · Company UpdateJan 10, 20258-KDelisting NoticeJan 8, 2025SC 13GSC 13GNov 14, 202410-Q10-QNov 14, 20248-KResults of OperationsNov 14, 20248-KShareholder VoteOct 24, 2024SC 13GSC 13GOct 16, 20248-KExecutive ChangeOct 10, 2024DEFA14ADEFA14ASep 9, 2024DEF 14ADEF 14ASep 9, 202410-Q10-QAug 8, 20248-KResults of OperationsAug 8, 2024SC 13GSC 13GAug 5, 20248-KCompany UpdateJul 29, 20248-KMaterial Agreement · Equity IssuanceJul 26, 20248-KReg FD Disclosure · Company UpdateJul 26, 20248-KDelisting NoticeJul 5, 20248-KShareholder VoteJun 14, 202410-Q10-QMay 14, 20248-KResults of OperationsMay 14, 20248-KReg FD Disclosure · Company UpdateApr 30, 2024DEFA14ADEFA14AApr 25, 2024DEF 14ADEF 14AApr 25, 2024424B5424B5Apr 1, 202410-K10-KApr 1, 20248-KResults of OperationsApr 1, 20248-KMaterial AgreementJan 5, 2024424B5424B5Jan 5, 20248-KExecutive Change · Reg FD DisclosureJan 3, 20248-KMaterial Agreement · Equity IssuanceDec 8, 20238-KReg FD DisclosureNov 20, 20238-KResults of OperationsNov 14, 202310-Q10-QNov 14, 2023SC 13GSC 13GAug 30, 20238-KMaterial Agreement · Equity IssuanceAug 22, 20238-KResults of OperationsAug 14, 202310-Q10-QAug 14, 20238-KSecurity-Holder Rights · Bylaw AmendmentJul 14, 20238-KCompany UpdateJul 10, 20238-KShareholder VoteJun 30, 2023DEF 14ADEF 14AJun 1, 2023
Insider Activity
◆ Cluster Buy · 3 insidersIn the 90 days to Mar 5, 2026: 3 insiders bought $8.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 5, 2026 | Williams EugeneDirector | Buy | 2,000 | $24.40 | $49K |
| Mar 4, 2026 | Williams EugeneDirector | Buy | 2,000 | $24.00 | $48K |
| Mar 3, 2026 | Williams EugeneDirector | Buy | 1,000 | $21.89 | $22K |
| Mar 2, 2026 | Williams EugeneDirector | Buy | 1,000 | $22.53 | $23K |
| Feb 19, 2026 | Kaplan JohanneChief Development Officer | Buy | 1,629 | $15.35 | $25K |
| Feb 3, 2026 | Yu FanTenPercentOwner | Buy | 700,741 | $12.13 | $8.5M |
| Oct 3, 2025 | Milbury Max A.Other | Buy | 30,392 | $0.49 | $15K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance